iOS app Android app

Sovaldi Hepatitis C

Gilead Sciences: A Profile in Congressionally Guaranteed Profiteering

David Belk | Posted 04.11.2015 | Business
David Belk

Industries have every right to make a profit. But should any industry be allowed unbridled profits by outlawing any possible check on their prices? A market is supposed to have two sides negotiating prices.

Drugs and Dollars

David Blumenthal | Posted 09.30.2014 | Politics
David Blumenthal

Tough as it is, having highly effective, but expensive, new treatments is a good problem to have. These drugs mean longer, better lives for humans the world over. We need to foster competitive markets and public policies that enable us to benefit.

Is This Hepatitis C Treatment Worth $1,000 A Pill?

AP | MATTHEW PERRONE | Posted 03.11.2014 | Healthy Living

WASHINGTON (AP) — An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health car...

Breakthrough Hepatitis C Drug Approved By FDA

AP | AP Health Writer | Posted 02.08.2014 | Healthy Living

WASHINGTON (AP) — Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a...